Scala,Inc. (4845.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

14.2x

EV/EBITDA

7.0x

Market Cap

JPY 6.11B

MomentumView details →

1D Return

+0.00%

YTD Return

−7.55%

RSI (14)

57.1

ValuationView details →

P/E (Fwd)

14.2x

EV/EBITDA

7.0x

Market Cap

JPY 6.11B

RSI (14)

57.1

MomentumView details →

1D Return

+0.00%

YTD Return

−7.55%

ProfitabilityView details →

Gross Margin

53.53%

Net Margin

8.71%

EBITDA Margin

14.26%

ROE (TTM)

13.61%

ROA (TTM)

6.43%

Asset Turnover

0.74x

GrowthView details →

Revenue YoY

−24.84%

EPS YoY

+128.07%

FCF YoY

−85.76%

Revenue CAGR 3Y

−6.53%

EPS CAGR 3Y

+133.98%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

1.81x

Quick Ratio

1.69x

Div Yield

2.41%

Div Rate

JPY 16.50

Div Growth 1Y

−56.00%

Financials snapshotView financials →

Revenue (TTM)

7.38B

Net Income (TTM)

643.00M

Op. CF (TTM)

187.11M

Next earningsNov 16, 2026 →

Latest newsMore news →

Scala Inc. announced its consolidated financial results for the fiscal year ending June 2026, with revenue increasing 4.3% year-on-year to 8.533 billion yen, operating profit decreasing 6.0% to 528 million yen, and net profit attributable to owners decreasing 19.2% to 301 million yen.19d ago

Similar companies

WDB coco CO.,LTD.7079.T TriIs Incorporated4840.T geechs inc.7060.T SAPPORO CLINICAL LABORATORY INC.9776.T GMO Product Platform,Inc.3695.T coconala Inc.4176.T Find similar companies →

Latest newsMore news →

Scala Inc. announced its consolidated financial results for the fiscal year ending June 2026, with revenue increasing 4.3% year-on-year to 8.533 billion yen, operating profit decreasing 6.0% to 528 million yen, and net profit attributable to owners decreasing 19.2% to 301 million yen.19d ago